HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Caruthers, R. L. Articles by Johnson, C. E. Search for Related Content PubMed PubMed Citation Articles by Caruthers, R. L. Articles by Johnson, C. E.

REGINEL. CARUTHERS, PHARM.D., is Clinical Pharmacist, Pediatric Cardiothoracic Unit, University of Michigan Hospitals and Health Centers (UMHHC), Ann Arbor, and Adjunct Clinical Instructor of Pharmacy, College of Pharmacy, University of Michigan (UM), Ann Arbor. CARYE. JOHNSON, PHARM.D., FASHP, is Professor of Pharmacy, Department of Clinical Sciences, College of Pharmacy, UM, and Clinical Pharmacist—Pediatrics, Department of Pharmacy, UMHHC.

Address correspondence to Dr. Caruthers at the College of Pharmacy, University of Michigan, 1500 East Medical Center Drive, UHB2D301, Box 0008, Ann Arbor, MI 48109-0008 (rcaruthe{at}med.umich.edu).

Purpose. In an effort to minimize barriers to compliance and adherence and to improve the accuracy of dosage measurement, sugar-containing and sugar-free sodium phenylbutyrate suspensions were formulated, and the stability of these products over a 90-day period was determined. Methods. An oral suspension of sodium phenylbutyrate 200 mg/mL was prepared by thoroughly grinding 12 g of Sodium Phenylbutyrate Powder, USP, in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of either Ora-Sweet or Ora-Sweet SF were mixed and added to the powder to make a final volume of 60 mL. Three identical samples of each formulation were prepared and placed in 2-oz amber plastic bottles with child-resistant caps and were stored at room temperature. A 500-µL sample was withdrawn from each of the six bottles with a micropipette immediately after preparation and at 7, 14, 28, 60, and 90 days. After further dilution to an expected concentration of 100 µg/mL with the mobile phase, the samples were assayed by high-performance liquid chromatography. Stability was defined as the retention of at least 90% of the initial concentration. Results. At least 95% of the initial sodium phenylbutyrate concentration remained throughout the 90-day study period in both preparations. There were no detectable changes in color, odor, taste, and pH and no visible microbial growth in any sample. Conclusion. Extemporaneously compounded suspensions of sodium phenylbutyrate, 200 mg/mL, in a 1:1 mixture of Ora-Plus and Ora-Sweet or Ora-Sweet SF were stable for at least 90 days when stored in 2-oz amber plastic bottles at room temperature. Index terms: Antihyperammonemic agents; Color; Compounding; Concentration; Contamination; Hydrogen ion concentration; Odors; Sodium phenylbutyrate; Stability; Storage; Suspensions; Taste; Vehicles

 

This article has been cited by other articles:

				F. Navid, R. Christensen, P. Minkin, C. F Stewart, W. L Furman, and S. Baker Stability of Sunitinib in Oral Suspension Ann. Pharmacother., July 1, 2008; 42(7): 962 - 966. [Abstract] [Full Text] [PDF]